OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 126,700
+4,300 (3.51%)
Feb 9, 2026, 10:43 AM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.47 trillion as of February 6, 2026. Its market cap has increased by 752.70% in one year.
Market Cap
2.47T
Enterprise Value
2.36T
Revenue
10.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
126,700.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.47T, an increase of 485.57%. That is a compound annual growth rate of 26.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 2.47T | -12.82% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 6.95T |
| LigaChem Biosciences | 6.63T |
| Peptron | 6.39T |
| Voronoi | 3.93T |
| SK bioscience | 3.82T |
| D&D Pharmatech | 3.74T |
| PharmaResearch | 3.53T |
| Hugel | 2.63T |